Press Releases

Sadly the United Nations High Level Panel ignored the real issues that impact or delay delivery of innovative treatments and cures throughout the developing world, while focusing on policy recommendations in the one area –…

BIO announced programming for the 15th annual BIO Investor Forum. Held on October 18-19 at the Westin St. Francis Hotel in San Francisco, the BIO Investor Forum explores global investment trends and opportunities in life sciences. Early and mid…

BIO released the new report “Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond,” documenting substantial, ongoing growth in the renewable chemical industry and…

BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money.  The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which…

Pennsylvania’s concentration of bioscience employment is nine percent greater than national average

Meeting will bring together biotechnology executives, academics and investors from around the globe 

Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility…

BIO and Pennsylvania Bio commend Governor Tom Wolf for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.

Washington, D.C. (July 15, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding the Prescription Drug User Fee Act (PDUFA) VI goals letter:

BIO and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions® offerings.